Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes Article Swipe
Veeral Ajmera
,
Kaleb Tesfai
,
Erick Sandoval
,
Scarlett Lopez
,
Vanessa Cervantes
,
Egbert Madamba
,
Ricki Bettencourt
,
Pinelopi Manousou
,
Lisa Richards
,
Rohit Loomba
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1097/hep.0000000000000635
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1097/hep.0000000000000635
Background and Aims: Recently, the American Gastroenterological Association and the American Association for the Study of Liver Diseases developed clinical pathways to evaluate populations at high risk for NAFLD. We assessed the diagnostic performance of the new guidance in a well-phenotyped cohort of patients with Type 2 diabetes mellitus (T2DM). Approach and Results: This prospective study enrolled patients age ≥50 years with T2DM. Participants underwent a standardized clinical research visit with MRI and ultrasound-based assessment of liver fat and stiffness and Enhanced Liver Fibrosis (ELF) testing. Of 417 participants (36% men) with T2DM with FIB-4 and MRE data, the prevalence of NAFLD was 64% and 12% had advanced fibrosis (MRE≥3.63 kPa). Applying the American Gastroenterological Association pathway of FIB-4 and vibration-controlled transient elastography, the false negative rate was 3.3% and 18% would qualify for specialty referral. Applying the FIB-4 + ELF American Association for the Study of Liver Diseases pathway, the false negative rate was 4.5%, but 50% would qualify for specialty referral. Applying higher ELF cut points improved the pathway, yielding a similar false negative rate of 4.9% but decreased specialty referral to 27%. Conclusion: Validation of the American Gastroenterological Association clinical pathway in a prospectively recruited cohort with T2DM revealed a low false negative rate and avoided specialty referral in a large percentage of patients. The American Association for the Study of Liver Diseases pathway with FIB-4 + ELF resulted in a high rate of specialty referral, which improved with the utilization of higher ELF cut points and may serve as an alternative for primary care and endocrinology clinics without access to vibration-controlled transient elastography.
Related Topics
Concepts
Nonalcoholic fatty liver disease
Medicine
Type 2 diabetes
Internal medicine
Prospective cohort study
Cohort
Clinical Practice
Diabetes mellitus
Cohort study
Fatty liver
Disease
Gastroenterology
Endocrinology
Family medicine
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/hep.0000000000000635
- OA Status
- green
- Cited By
- 19
- References
- 35
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4387823662
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4387823662Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/hep.0000000000000635Digital Object Identifier
- Title
-
Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-10-20Full publication date if available
- Authors
-
Veeral Ajmera, Kaleb Tesfai, Erick Sandoval, Scarlett Lopez, Vanessa Cervantes, Egbert Madamba, Ricki Bettencourt, Pinelopi Manousou, Lisa Richards, Rohit LoombaList of authors in order
- Landing page
-
https://doi.org/10.1097/hep.0000000000000635Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11023802Direct OA link when available
- Concepts
-
Nonalcoholic fatty liver disease, Medicine, Type 2 diabetes, Internal medicine, Prospective cohort study, Cohort, Clinical Practice, Diabetes mellitus, Cohort study, Fatty liver, Disease, Gastroenterology, Endocrinology, Family medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
19Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 10, 2024: 8, 2023: 1Per-year citation counts (last 5 years)
- References (count)
-
35Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4387823662 |
|---|---|
| doi | https://doi.org/10.1097/hep.0000000000000635 |
| ids.doi | https://doi.org/10.1097/hep.0000000000000635 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/37862551 |
| ids.openalex | https://openalex.org/W4387823662 |
| fwci | 6.70803353 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D008297 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Male |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D008875 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Middle Aged |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D005260 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Female |
| mesh[4].qualifier_ui | Q000175 |
| mesh[4].descriptor_ui | D065626 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | diagnosis |
| mesh[4].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[5].qualifier_ui | Q000453 |
| mesh[5].descriptor_ui | D065626 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | epidemiology |
| mesh[5].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[6].qualifier_ui | Q000628 |
| mesh[6].descriptor_ui | D065626 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | therapy |
| mesh[6].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D011446 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Prospective Studies |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D019091 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Critical Pathways |
| mesh[9].qualifier_ui | Q000150 |
| mesh[9].descriptor_ui | D003924 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | complications |
| mesh[9].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[10].qualifier_ui | Q000628 |
| mesh[10].descriptor_ui | D003924 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | therapy |
| mesh[10].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[11].qualifier_ui | Q000453 |
| mesh[11].descriptor_ui | D003924 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | epidemiology |
| mesh[11].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[12].qualifier_ui | Q000000981 |
| mesh[12].descriptor_ui | D008099 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | diagnostic imaging |
| mesh[12].descriptor_name | Liver |
| mesh[13].qualifier_ui | Q000473 |
| mesh[13].descriptor_ui | D008099 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | pathology |
| mesh[13].descriptor_name | Liver |
| mesh[14].qualifier_ui | Q000150 |
| mesh[14].descriptor_ui | D008103 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | complications |
| mesh[14].descriptor_name | Liver Cirrhosis |
| mesh[15].qualifier_ui | Q000379 |
| mesh[15].descriptor_ui | D054459 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | methods |
| mesh[15].descriptor_name | Elasticity Imaging Techniques |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D008297 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Male |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D006801 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Humans |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D008875 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Middle Aged |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D005260 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Female |
| mesh[20].qualifier_ui | Q000175 |
| mesh[20].descriptor_ui | D065626 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | diagnosis |
| mesh[20].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[21].qualifier_ui | Q000453 |
| mesh[21].descriptor_ui | D065626 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | epidemiology |
| mesh[21].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[22].qualifier_ui | Q000628 |
| mesh[22].descriptor_ui | D065626 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | therapy |
| mesh[22].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D011446 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Prospective Studies |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D019091 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Critical Pathways |
| mesh[25].qualifier_ui | Q000150 |
| mesh[25].descriptor_ui | D003924 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | complications |
| mesh[25].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[26].qualifier_ui | Q000628 |
| mesh[26].descriptor_ui | D003924 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapy |
| mesh[26].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[27].qualifier_ui | Q000453 |
| mesh[27].descriptor_ui | D003924 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | epidemiology |
| mesh[27].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[28].qualifier_ui | Q000000981 |
| mesh[28].descriptor_ui | D008099 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | diagnostic imaging |
| mesh[28].descriptor_name | Liver |
| mesh[29].qualifier_ui | Q000473 |
| mesh[29].descriptor_ui | D008099 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | pathology |
| mesh[29].descriptor_name | Liver |
| mesh[30].qualifier_ui | Q000150 |
| mesh[30].descriptor_ui | D008103 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | complications |
| mesh[30].descriptor_name | Liver Cirrhosis |
| mesh[31].qualifier_ui | Q000379 |
| mesh[31].descriptor_ui | D054459 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | methods |
| mesh[31].descriptor_name | Elasticity Imaging Techniques |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D008297 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Male |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D006801 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Humans |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D008875 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Middle Aged |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D005260 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Female |
| mesh[36].qualifier_ui | Q000175 |
| mesh[36].descriptor_ui | D065626 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | diagnosis |
| mesh[36].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[37].qualifier_ui | Q000453 |
| mesh[37].descriptor_ui | D065626 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | epidemiology |
| mesh[37].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[38].qualifier_ui | Q000628 |
| mesh[38].descriptor_ui | D065626 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | therapy |
| mesh[38].descriptor_name | Non-alcoholic Fatty Liver Disease |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D011446 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Prospective Studies |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D019091 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Critical Pathways |
| mesh[41].qualifier_ui | Q000150 |
| mesh[41].descriptor_ui | D003924 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | complications |
| mesh[41].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[42].qualifier_ui | Q000628 |
| mesh[42].descriptor_ui | D003924 |
| mesh[42].is_major_topic | True |
| mesh[42].qualifier_name | therapy |
| mesh[42].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[43].qualifier_ui | Q000453 |
| mesh[43].descriptor_ui | D003924 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | epidemiology |
| mesh[43].descriptor_name | Diabetes Mellitus, Type 2 |
| mesh[44].qualifier_ui | Q000000981 |
| mesh[44].descriptor_ui | D008099 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | diagnostic imaging |
| mesh[44].descriptor_name | Liver |
| mesh[45].qualifier_ui | Q000473 |
| mesh[45].descriptor_ui | D008099 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | pathology |
| mesh[45].descriptor_name | Liver |
| mesh[46].qualifier_ui | Q000150 |
| mesh[46].descriptor_ui | D008103 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | complications |
| mesh[46].descriptor_name | Liver Cirrhosis |
| mesh[47].qualifier_ui | Q000379 |
| mesh[47].descriptor_ui | D054459 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | methods |
| mesh[47].descriptor_name | Elasticity Imaging Techniques |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D008297 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Male |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D006801 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Humans |
| type | article |
| title | Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes |
| biblio.issue | 5 |
| biblio.volume | 79 |
| biblio.last_page | 1106 |
| biblio.first_page | 1098 |
| topics[0].id | https://openalex.org/T10351 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Liver Disease Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T10499 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.982699990272522 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Folate and B Vitamins Research |
| topics[2].id | https://openalex.org/T10552 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9824000000953674 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Colorectal Cancer Screening and Detection |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776954865 |
| concepts[0].level | 4 |
| concepts[0].score | 0.8977869749069214 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1546498 |
| concepts[0].display_name | Nonalcoholic fatty liver disease |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.864357590675354 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2777180221 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6814939379692078 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[2].display_name | Type 2 diabetes |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.6435874700546265 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C188816634 |
| concepts[4].level | 2 |
| concepts[4].score | 0.6308581829071045 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[4].display_name | Prospective cohort study |
| concepts[5].id | https://openalex.org/C72563966 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5140150785446167 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[5].display_name | Cohort |
| concepts[6].id | https://openalex.org/C2779974597 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4765230417251587 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q28448986 |
| concepts[6].display_name | Clinical Practice |
| concepts[7].id | https://openalex.org/C555293320 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4667387902736664 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[7].display_name | Diabetes mellitus |
| concepts[8].id | https://openalex.org/C201903717 |
| concepts[8].level | 2 |
| concepts[8].score | 0.44974803924560547 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[8].display_name | Cohort study |
| concepts[9].id | https://openalex.org/C2778772119 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4281572699546814 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q6058862 |
| concepts[9].display_name | Fatty liver |
| concepts[10].id | https://openalex.org/C2779134260 |
| concepts[10].level | 2 |
| concepts[10].score | 0.42024242877960205 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[10].display_name | Disease |
| concepts[11].id | https://openalex.org/C90924648 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3615201711654663 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q120569 |
| concepts[11].display_name | Gastroenterology |
| concepts[12].id | https://openalex.org/C134018914 |
| concepts[12].level | 1 |
| concepts[12].score | 0.20973557233810425 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[12].display_name | Endocrinology |
| concepts[13].id | https://openalex.org/C512399662 |
| concepts[13].level | 1 |
| concepts[13].score | 0.17722493410110474 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[13].display_name | Family medicine |
| keywords[0].id | https://openalex.org/keywords/nonalcoholic-fatty-liver-disease |
| keywords[0].score | 0.8977869749069214 |
| keywords[0].display_name | Nonalcoholic fatty liver disease |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.864357590675354 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[2].score | 0.6814939379692078 |
| keywords[2].display_name | Type 2 diabetes |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.6435874700546265 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[4].score | 0.6308581829071045 |
| keywords[4].display_name | Prospective cohort study |
| keywords[5].id | https://openalex.org/keywords/cohort |
| keywords[5].score | 0.5140150785446167 |
| keywords[5].display_name | Cohort |
| keywords[6].id | https://openalex.org/keywords/clinical-practice |
| keywords[6].score | 0.4765230417251587 |
| keywords[6].display_name | Clinical Practice |
| keywords[7].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[7].score | 0.4667387902736664 |
| keywords[7].display_name | Diabetes mellitus |
| keywords[8].id | https://openalex.org/keywords/cohort-study |
| keywords[8].score | 0.44974803924560547 |
| keywords[8].display_name | Cohort study |
| keywords[9].id | https://openalex.org/keywords/fatty-liver |
| keywords[9].score | 0.4281572699546814 |
| keywords[9].display_name | Fatty liver |
| keywords[10].id | https://openalex.org/keywords/disease |
| keywords[10].score | 0.42024242877960205 |
| keywords[10].display_name | Disease |
| keywords[11].id | https://openalex.org/keywords/gastroenterology |
| keywords[11].score | 0.3615201711654663 |
| keywords[11].display_name | Gastroenterology |
| keywords[12].id | https://openalex.org/keywords/endocrinology |
| keywords[12].score | 0.20973557233810425 |
| keywords[12].display_name | Endocrinology |
| keywords[13].id | https://openalex.org/keywords/family-medicine |
| keywords[13].score | 0.17722493410110474 |
| keywords[13].display_name | Family medicine |
| language | en |
| locations[0].id | doi:10.1097/hep.0000000000000635 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S156174673 |
| locations[0].source.issn | 0270-9139, 1527-3350 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0270-9139 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Hepatology |
| locations[0].source.host_organization | https://openalex.org/P4310315671 |
| locations[0].source.host_organization_name | Lippincott Williams & Wilkins |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315671 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Hepatology |
| locations[0].landing_page_url | https://doi.org/10.1097/hep.0000000000000635 |
| locations[1].id | pmid:37862551 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Hepatology (Baltimore, Md.) |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/37862551 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11023802 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Hepatology |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11023802 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5028383260 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5626-0942 |
| authorships[0].author.display_name | Veeral Ajmera |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I36258959 |
| authorships[0].affiliations[1].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[0].institutions[0].id | https://openalex.org/I36258959 |
| authorships[0].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of California, San Diego |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Veeral Ajmera |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA, NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[1].author.id | https://openalex.org/A5055533574 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5968-2294 |
| authorships[1].author.display_name | Kaleb Tesfai |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[1].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[1].institutions[0].id | https://openalex.org/I36258959 |
| authorships[1].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | University of California, San Diego |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Kaleb Tesfai |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[2].author.id | https://openalex.org/A5003054486 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Erick Sandoval |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[2].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[2].institutions[0].id | https://openalex.org/I36258959 |
| authorships[2].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | University of California, San Diego |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Erick Sandoval |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[3].author.id | https://openalex.org/A5023476512 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Scarlett Lopez |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[3].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[3].institutions[0].id | https://openalex.org/I36258959 |
| authorships[3].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | University of California, San Diego |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Scarlett Lopez |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[4].author.id | https://openalex.org/A5076532994 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-5512-7493 |
| authorships[4].author.display_name | Vanessa Cervantes |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[4].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[4].institutions[0].id | https://openalex.org/I36258959 |
| authorships[4].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | University of California, San Diego |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Vanessa Cervantes |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[5].author.id | https://openalex.org/A5002250826 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4065-3538 |
| authorships[5].author.display_name | Egbert Madamba |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[5].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[5].institutions[0].id | https://openalex.org/I36258959 |
| authorships[5].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | University of California, San Diego |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Egbert Madamba |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[6].author.id | https://openalex.org/A5063837839 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-6267-1078 |
| authorships[6].author.display_name | Ricki Bettencourt |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[6].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[6].institutions[0].id | https://openalex.org/I36258959 |
| authorships[6].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | University of California, San Diego |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Ricki Bettencourt |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[7].author.id | https://openalex.org/A5091376840 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-5363-1565 |
| authorships[7].author.display_name | Pinelopi Manousou |
| authorships[7].countries | GB |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[7].affiliations[0].raw_affiliation_string | Liver unit/Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom |
| authorships[7].institutions[0].id | https://openalex.org/I47508984 |
| authorships[7].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[7].institutions[0].country_code | GB |
| authorships[7].institutions[0].display_name | Imperial College London |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Pinelopi Manousou |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Liver unit/Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom |
| authorships[8].author.id | https://openalex.org/A5112359720 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Lisa Richards |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[8].affiliations[0].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[8].institutions[0].id | https://openalex.org/I36258959 |
| authorships[8].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | University of California, San Diego |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Lisa Richards |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[9].author.id | https://openalex.org/A5052059601 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-4845-9991 |
| authorships[9].author.display_name | Rohit Loomba |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I36258959 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA |
| authorships[9].affiliations[1].institution_ids | https://openalex.org/I36258959 |
| authorships[9].affiliations[1].raw_affiliation_string | School of Public Health, University of California at San Diego, La Jolla, California, USA |
| authorships[9].affiliations[2].institution_ids | https://openalex.org/I36258959 |
| authorships[9].affiliations[2].raw_affiliation_string | NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA |
| authorships[9].institutions[0].id | https://openalex.org/I36258959 |
| authorships[9].institutions[0].ror | https://ror.org/0168r3w48 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I36258959 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | University of California, San Diego |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | Rohit Loomba |
| authorships[9].is_corresponding | True |
| authorships[9].raw_affiliation_strings | Division of Gastroenterology and Hepatology, University of California at San Diego, La Jolla, California, USA, NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, California, USA, School of Public Health, University of California at San Diego, La Jolla, California, USA |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11023802 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10351 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Liver Disease Diagnosis and Treatment |
| related_works | https://openalex.org/W2789871051, https://openalex.org/W2411601854, https://openalex.org/W3029098362, https://openalex.org/W2350745226, https://openalex.org/W3178651159, https://openalex.org/W2369510609, https://openalex.org/W2109188472, https://openalex.org/W561124343, https://openalex.org/W1989961712, https://openalex.org/W3091937932 |
| cited_by_count | 19 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 10 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 8 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11023802 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | Hepatology |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11023802 |
| primary_location.id | doi:10.1097/hep.0000000000000635 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S156174673 |
| primary_location.source.issn | 0270-9139, 1527-3350 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0270-9139 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Hepatology |
| primary_location.source.host_organization | https://openalex.org/P4310315671 |
| primary_location.source.host_organization_name | Lippincott Williams & Wilkins |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315671 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Hepatology |
| primary_location.landing_page_url | https://doi.org/10.1097/hep.0000000000000635 |
| publication_date | 2023-10-20 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W2204688218, https://openalex.org/W3023600519, https://openalex.org/W4288010199, https://openalex.org/W2105359426, https://openalex.org/W2977362851, https://openalex.org/W4309474217, https://openalex.org/W4383093105, https://openalex.org/W4385237448, https://openalex.org/W4367397089, https://openalex.org/W3201482376, https://openalex.org/W2988945504, https://openalex.org/W4318923555, https://openalex.org/W2546306361, https://openalex.org/W2808200121, https://openalex.org/W4367301730, https://openalex.org/W2938096756, https://openalex.org/W2022296797, https://openalex.org/W2138306815, https://openalex.org/W1614032175, https://openalex.org/W1926691574, https://openalex.org/W2314336137, https://openalex.org/W2064387090, https://openalex.org/W2767268548, https://openalex.org/W1982702940, https://openalex.org/W4292560094, https://openalex.org/W4283819266, https://openalex.org/W4285087410, https://openalex.org/W4365455620, https://openalex.org/W3162773903, https://openalex.org/W4226414225, https://openalex.org/W4283770030, https://openalex.org/W4200339468, https://openalex.org/W4210740455, https://openalex.org/W4383872179, https://openalex.org/W4295074172 |
| referenced_works_count | 35 |
| abstract_inverted_index.+ | 139, 229 |
| abstract_inverted_index.2 | 46 |
| abstract_inverted_index.a | 39, 65, 172, 195, 202, 212, 233 |
| abstract_inverted_index.Of | 86 |
| abstract_inverted_index.We | 29 |
| abstract_inverted_index.an | 253 |
| abstract_inverted_index.as | 252 |
| abstract_inverted_index.at | 24 |
| abstract_inverted_index.in | 38, 194, 211, 232 |
| abstract_inverted_index.of | 15, 34, 42, 75, 100, 117, 146, 177, 187, 215, 223, 236, 244 |
| abstract_inverted_index.to | 21, 183, 263 |
| abstract_inverted_index.12% | 105 |
| abstract_inverted_index.18% | 130 |
| abstract_inverted_index.417 | 87 |
| abstract_inverted_index.50% | 157 |
| abstract_inverted_index.64% | 103 |
| abstract_inverted_index.ELF | 140, 165, 230, 246 |
| abstract_inverted_index.MRE | 96 |
| abstract_inverted_index.MRI | 71 |
| abstract_inverted_index.The | 217 |
| abstract_inverted_index.age | 58 |
| abstract_inverted_index.and | 1, 8, 51, 72, 78, 80, 95, 104, 119, 129, 207, 249, 258 |
| abstract_inverted_index.but | 156, 179 |
| abstract_inverted_index.cut | 166, 247 |
| abstract_inverted_index.fat | 77 |
| abstract_inverted_index.for | 12, 27, 133, 143, 160, 220, 255 |
| abstract_inverted_index.had | 106 |
| abstract_inverted_index.low | 203 |
| abstract_inverted_index.may | 250 |
| abstract_inverted_index.new | 36 |
| abstract_inverted_index.the | 4, 9, 13, 31, 35, 98, 112, 123, 137, 144, 150, 169, 188, 221, 242 |
| abstract_inverted_index.was | 102, 127, 154 |
| abstract_inverted_index.(36% | 89 |
| abstract_inverted_index.27%. | 184 |
| abstract_inverted_index.3.3% | 128 |
| abstract_inverted_index.4.9% | 178 |
| abstract_inverted_index.T2DM | 92, 200 |
| abstract_inverted_index.This | 53 |
| abstract_inverted_index.Type | 45 |
| abstract_inverted_index.care | 257 |
| abstract_inverted_index.high | 25, 234 |
| abstract_inverted_index.men) | 90 |
| abstract_inverted_index.rate | 126, 153, 176, 206, 235 |
| abstract_inverted_index.risk | 26 |
| abstract_inverted_index.with | 44, 61, 70, 91, 93, 199, 227, 241 |
| abstract_inverted_index.(ELF) | 84 |
| abstract_inverted_index.4.5%, | 155 |
| abstract_inverted_index.Aims: | 2 |
| abstract_inverted_index.FIB-4 | 94, 118, 138, 228 |
| abstract_inverted_index.Liver | 16, 82, 147, 224 |
| abstract_inverted_index.NAFLD | 101 |
| abstract_inverted_index.Study | 14, 145, 222 |
| abstract_inverted_index.T2DM. | 62 |
| abstract_inverted_index.data, | 97 |
| abstract_inverted_index.false | 124, 151, 174, 204 |
| abstract_inverted_index.kPa). | 110 |
| abstract_inverted_index.large | 213 |
| abstract_inverted_index.liver | 76 |
| abstract_inverted_index.serve | 251 |
| abstract_inverted_index.study | 55 |
| abstract_inverted_index.visit | 69 |
| abstract_inverted_index.which | 239 |
| abstract_inverted_index.would | 131, 158 |
| abstract_inverted_index.years | 60 |
| abstract_inverted_index.≥50 | 59 |
| abstract_inverted_index.NAFLD. | 28 |
| abstract_inverted_index.access | 262 |
| abstract_inverted_index.cohort | 41, 198 |
| abstract_inverted_index.higher | 164, 245 |
| abstract_inverted_index.points | 167, 248 |
| abstract_inverted_index.(T2DM). | 49 |
| abstract_inverted_index.avoided | 208 |
| abstract_inverted_index.clinics | 260 |
| abstract_inverted_index.pathway | 116, 193, 226 |
| abstract_inverted_index.primary | 256 |
| abstract_inverted_index.qualify | 132, 159 |
| abstract_inverted_index.similar | 173 |
| abstract_inverted_index.without | 261 |
| abstract_inverted_index.American | 5, 10, 113, 141, 189, 218 |
| abstract_inverted_index.Applying | 111, 136, 163 |
| abstract_inverted_index.Approach | 50 |
| abstract_inverted_index.Diseases | 17, 148, 225 |
| abstract_inverted_index.Enhanced | 81 |
| abstract_inverted_index.Fibrosis | 83 |
| abstract_inverted_index.Results: | 52 |
| abstract_inverted_index.advanced | 107 |
| abstract_inverted_index.assessed | 30 |
| abstract_inverted_index.clinical | 19, 67, 192 |
| abstract_inverted_index.diabetes | 47 |
| abstract_inverted_index.enrolled | 56 |
| abstract_inverted_index.evaluate | 22 |
| abstract_inverted_index.fibrosis | 108 |
| abstract_inverted_index.guidance | 37 |
| abstract_inverted_index.improved | 168, 240 |
| abstract_inverted_index.mellitus | 48 |
| abstract_inverted_index.negative | 125, 152, 175, 205 |
| abstract_inverted_index.pathway, | 149, 170 |
| abstract_inverted_index.pathways | 20 |
| abstract_inverted_index.patients | 43, 57 |
| abstract_inverted_index.referral | 182, 210 |
| abstract_inverted_index.research | 68 |
| abstract_inverted_index.resulted | 231 |
| abstract_inverted_index.revealed | 201 |
| abstract_inverted_index.testing. | 85 |
| abstract_inverted_index.yielding | 171 |
| abstract_inverted_index.Recently, | 3 |
| abstract_inverted_index.decreased | 180 |
| abstract_inverted_index.developed | 18 |
| abstract_inverted_index.patients. | 216 |
| abstract_inverted_index.recruited | 197 |
| abstract_inverted_index.referral, | 238 |
| abstract_inverted_index.referral. | 135, 162 |
| abstract_inverted_index.specialty | 134, 161, 181, 209, 237 |
| abstract_inverted_index.stiffness | 79 |
| abstract_inverted_index.transient | 121, 265 |
| abstract_inverted_index.underwent | 64 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.Validation | 186 |
| abstract_inverted_index.assessment | 74 |
| abstract_inverted_index.diagnostic | 32 |
| abstract_inverted_index.percentage | 214 |
| abstract_inverted_index.prevalence | 99 |
| abstract_inverted_index.(MRE≥3.63 | 109 |
| abstract_inverted_index.Association | 7, 11, 115, 142, 191, 219 |
| abstract_inverted_index.Conclusion: | 185 |
| abstract_inverted_index.alternative | 254 |
| abstract_inverted_index.performance | 33 |
| abstract_inverted_index.populations | 23 |
| abstract_inverted_index.prospective | 54 |
| abstract_inverted_index.utilization | 243 |
| abstract_inverted_index.Participants | 63 |
| abstract_inverted_index.participants | 88 |
| abstract_inverted_index.standardized | 66 |
| abstract_inverted_index.elastography, | 122 |
| abstract_inverted_index.elastography. | 266 |
| abstract_inverted_index.endocrinology | 259 |
| abstract_inverted_index.prospectively | 196 |
| abstract_inverted_index.well-phenotyped | 40 |
| abstract_inverted_index.ultrasound-based | 73 |
| abstract_inverted_index.Gastroenterological | 6, 114, 190 |
| abstract_inverted_index.vibration-controlled | 120, 264 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5052059601 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 10 |
| corresponding_institution_ids | https://openalex.org/I36258959 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6600000262260437 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.95977639 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |